
Aerpio Pharmaceuticals, Inc. ARPO
Aerpio Pharmaceuticals, Inc. Operating Expenses 2011-2025 | ARPO
Annual Operating Expenses Aerpio Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 21.3 M | 22.4 M | 31.3 M | 21.4 M | 29.5 K | 23 K | 22.8 K | 22.4 K | 23.6 K | 20.5 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.3 M | 20.5 K | 9.66 M |
Operating Expenses of other stocks in the Biotechnology industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
432 M | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
96.2 M | $ 4.79 | -0.1 % | $ 795 M | ||
|
Aclaris Therapeutics
ACRS
|
92.7 M | $ 3.02 | -0.66 % | $ 233 M | ||
|
Aeglea BioTherapeutics
AGLE
|
209 M | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
88.2 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
65.4 M | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 M | $ 0.21 | 22.69 % | $ 457 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.66 B | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
20.7 M | $ 1.16 | -0.85 % | $ 6.33 M | ||
|
Ampio Pharmaceuticals
AMPE
|
9.57 M | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.22 M | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
127 M | - | - | $ 10.1 M | ||
|
Midatech Pharma plc
MTP
|
4.78 M | - | -18.52 % | $ 27.3 M | ||
|
Cellectar Biosciences
CLRB
|
15.3 M | $ 2.51 | -9.05 % | $ 30.7 M | ||
|
Ascendis Pharma A/S
ASND
|
338 M | $ 209.26 | -1.67 % | $ 5 B | ||
|
Aptevo Therapeutics
APVO
|
-31.8 M | $ 0.59 | -36.34 % | $ 163 K | ||
|
Alterity Therapeutics Limited
ATHE
|
16.7 M | $ 3.12 | 0.81 % | $ 7.51 B | ||
|
BioVie
BIVI
|
18.1 M | $ 1.22 | -4.33 % | $ 1.8 M | ||
|
Athersys
ATHX
|
79.8 M | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
629 M | - | - | - | ||
|
Avenue Therapeutics
ATXI
|
5.21 K | - | -52.27 % | $ 4.45 M | ||
|
ARCA biopharma
ABIO
|
88.1 M | - | 1052.0 % | $ 415 M | ||
|
AVROBIO
AVRO
|
71.7 M | - | 1083.1 % | $ 745 M | ||
|
Acasti Pharma
ACST
|
24.4 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
141 M | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
106 M | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
163 M | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
512 M | $ 94.66 | -0.39 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
168 M | $ 27.05 | 0.9 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
390 M | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
51.6 M | $ 9.6 | 1.21 % | $ 141 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
28.5 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
152 M | - | -7.31 % | $ 87 M | ||
|
Dynavax Technologies Corporation
DVAX
|
137 M | $ 15.38 | - | $ 2 B | ||
|
bluebird bio
BLUE
|
854 M | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
427 M | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
24.6 M | - | 2.71 % | $ 14 M | ||
|
Calithera Biosciences
CALA
|
125 M | - | -10.95 % | $ 876 K | ||
|
Eton Pharmaceuticals
ETON
|
22.3 M | $ 16.89 | -0.59 % | $ 433 M | ||
|
Evogene Ltd.
EVGN
|
28 M | $ 1.02 | -2.86 % | $ 27.9 M | ||
|
Axon Enterprise
AXON
|
1.18 B | $ 585.1 | -1.02 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
29.8 M | - | - | $ 7.46 M | ||
|
Exelixis
EXEL
|
598 M | $ 46.12 | -0.84 % | $ 13.4 B | ||
|
Aytu BioScience
AYTU
|
53.7 M | $ 2.48 | -2.17 % | $ 15.6 M | ||
|
AstraZeneca PLC
AZN
|
17.6 B | $ 92.69 | 0.26 % | $ 96.9 B | ||
|
Foghorn Therapeutics
FHTX
|
125 M | $ 5.4 | - | $ 296 M | ||
|
Acorda Therapeutics
ACOR
|
206 M | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
176 M | $ 12.3 | -0.61 % | $ 810 M | ||
|
Brickell Biotech
BBI
|
14.4 M | - | -5.38 % | $ 6.06 M |